Pharmafile Logo
Pharmafocus logo
Advanced Search

Herceptin

Showing 8 posts of 53 posts found.

Boehringer puts afatinib head-to-head with Herceptin

December 10, 2010
Research and Development BIBW 2992, Boehringer Ingelheim, Herceptin, Roche, Tovok, afatinib, breast cancer

Boehringer Ingelheim has set up a showdown between one of its pipeline oncology products and Roche’s Herceptin. It has started …

News

NICE recommends Herceptin for gastric cancer, blocks high dose Glivec

November 24, 2010
Sales and Marketing Cancer, GIST, Glivec, HER2, Herceptin, NICE, gastric cancer

NICE has recommended Roche’s cancer drug Herceptin for patients with HER2 metastatic gastric cancer. NICE was initially minded not to …

News
Herceptin packs

New Herceptin data sways NICE

September 30, 2010
Sales and Marketing Herceptin, NICE, Roche

NICE is now minded to approve Roche’s Herceptin for patients with metastatic gastric cancer after receiving new efficacy data from …

News

Roche submits new version of Herceptin for US approval

July 7, 2010
Research and Development, Sales and Marketing Herceptin, Roche, breast cancer

Roche has submitted a new version of its blockbuster Herceptin (trastuzumab) to US regulators for approval to treat advanced breast …

News
Herceptin packs

NICE set to block Herceptin for gastric cancer

July 6, 2010
Sales and Marketing Herceptin, NICE, Roche, gastric cancer

NICE’s preliminary draft guidance has not approved Roche’s Herceptin for gastric cancer as it failed to show how far the …

News

Roche expands Herceptin franchise

February 8, 2010
Sales and Marketing Herceptin, Roche, gastric cancer, stomach cancer

Roche’s blockbuster breast cancer treatment Herceptin has been launched in the UK as a treatment for stomach cancer. It is …

News

Roche invests in production of new Herceptin formulation

January 25, 2010
Manufacturing and Production, Research and Development Herceptin, Roche

Roche will spend 190 million Swiss francs ($183m) to put production capacity in place for a new self-administered formulation of …

News

Herceptin scientist wins Janssen award for biomedical research

September 8, 2009
Research and Development Herceptin, Janssen

Johnson & Johnson has honoured the career achievements of Axel Ullrich by awarding him with the 2009 Dr Paul Janssen …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025